胰岛素输送设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

胰岛素输送设备市场按类型(胰岛素泵、胰岛素注射器、可重复使用笔中的墨盒、一次性笔、喷射注射器)和地理划分。

胰岛素输送设备市场快照

insulin delivery devices market trends
Study Period: 2016-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 3.5 %
insulin delivery devices market major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计胰岛素输送设备市场在预测期内(2021-2026 年)的复合年增长率为 3.5%,到 2020 年收入将达到 339 亿美元。糖尿病在全球范围内迅速蔓延,极大地保持了对糖尿病相关研发的兴趣水平近年来高。尽管这种疾病影响了全世界数百万人,但科学家和研究人员一直未能找到治愈该疾病的方法。通过充分及时的胰岛素给药来控制它仍然是1型糖尿病患者过上正常生活必不可少的措施。因此,在糖尿病没有完全有效的治愈方法的情况下,重点主要在于使胰岛素治疗更好、更成功。因此,

报告范围

胰岛素输送设备市场细分为胰岛素泵、胰岛素注射器、可重复使用笔、一次性笔和喷射注射器中的墨盒,胰岛素泵进一步细分为胰岛素泵、胰岛素泵储液器和输液器。

By Management Devices
Insulin Pumps
Insulin Pump Devices (Value and Volume, 2016 - 2026)
Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)
Infusion Sets (Value and Volume, 2016 - 2026)
Insulin Syringes (Value and Volume, 2016 - 2026)
Cartridges in reusable pens (Value and Volume, 2016 - 2026)
Disposable Pens (Value and Volume, 2016 - 2026)
Jet Injectors (Value and Volume, 2016 - 2026)
Geography
North America
United States (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Canada (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of North America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Europe
France (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Germany (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Italy (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Spain (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
United Kingdom (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Russia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Europe (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Latin America
Mexico (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Brazil (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Latin America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Asia-Pacific
Japan (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Korea (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
China (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
India (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Australia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Vietnam (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Malaysia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Indonesia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Philippines (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Thailand (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Asia-Pacific (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Iran (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Egypt (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Oman (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

Report scope can be customized per your requirements. Click here.

主要市场趋势

胰岛素泵预计将以最高的复合年增长率增长

胰岛素泵在 2020 年占据了胰岛素输送设备市场 9.2% 的市场份额,并且由于技术进步的不断增加以及由于持续的胰岛素给药而对其他传统方法的偏好,预计该市场的复合年增长率将达到 7%。市场还受益于供应商数量的不断增加、研发活动、产品的技术进步以及全球先进产品的容易获得。此外,发达国家有利的报销方案以及发展中经济体意识计划的不断提高也有利于市场。

insulin delivery devices market share

美国在2020年占据主要市场份额

2020年,美国在胰岛素输送设备市场的市场份额最高,超过20%,其次是日本和印度。糖尿病患者人数的增加和技术先进设备的可及性是促成美国市场高速增长的因素。根据 2020 年魔多情报统计,美国约有 3300 万人患有糖尿病;其中,约 2580 万患者确诊,约 710 万患者仍未确诊。因此,患有糖尿病的庞大患者群及其不断增长的患病率预计将推动该地区的增长。

insulin delivery devices market growth

竞争格局

胰岛素笔和胰岛素泵市场由少数几家在 2020 年占据重要市场份额的参与者合并。另一方面,胰岛素注射器市场高度分散,有几家本地参与者。近期参与者之间发生的合并和收购帮助这些公司加强了他们的市场占有率。例如,2020 年 7 月,Medtronic PLC 和 Tandem Diabetes Care Inc. 宣布,他们就糖尿病领域的某些技术签订了非独家专利交叉许可协议。 

RECENT DEVELOPMENTS

In 2020, Gan & Lee’s insulin glargine injection and insulin glargine injection (prefilled pen) obtained the registration certificates from the Brazilian National Health Surveillance Agency (ANVISA). Following this, in early 2021, the first shipments of these products were successfully delivered to Brazil.

In Aug 2020, The U.S. Food and Drug Administration approved the MiniMed 770G System, a hybrid closed-loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabetes.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Management Devices

      1. 5.1.1 Insulin Pumps

        1. 5.1.1.1 Insulin Pump Devices (Value and Volume, 2016 - 2026)

        2. 5.1.1.2 Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)

        3. 5.1.1.3 Infusion Sets (Value and Volume, 2016 - 2026)

      2. 5.1.2 Insulin Syringes (Value and Volume, 2016 - 2026)

      3. 5.1.3 Cartridges in reusable pens (Value and Volume, 2016 - 2026)

      4. 5.1.4 Disposable Pens (Value and Volume, 2016 - 2026)

      5. 5.1.5 Jet Injectors (Value and Volume, 2016 - 2026)

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume, 2016 - 2026)

          1. 5.2.1.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.1.2 Canada (Value and Volume, 2016 - 2026)

          1. 5.2.1.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.1.3 Rest of North America (Value and Volume, 2016 - 2026)

          1. 5.2.1.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      2. 5.2.2 Europe

        1. 5.2.2.1 France (Value and Volume, 2016 - 2026)

          1. 5.2.2.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.2.2 Germany (Value and Volume, 2016 - 2026)

          1. 5.2.2.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.2.3 Italy (Value and Volume, 2016 - 2026)

          1. 5.2.2.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.2.4 Spain (Value and Volume, 2016 - 2026)

          1. 5.2.2.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.2.5 United Kingdom (Value and Volume, 2016 - 2026)

          1. 5.2.2.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.2.6 Russia (Value and Volume, 2016 - 2026)

          1. 5.2.2.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.2.7 Rest of Europe (Value and Volume, 2016 - 2026)

          1. 5.2.2.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico (Value and Volume, 2016 - 2026)

          1. 5.2.3.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.3.2 Brazil (Value and Volume, 2016 - 2026)

          1. 5.2.3.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.3.3 Rest of Latin America (Value and Volume, 2016 - 2026)

          1. 5.2.3.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan (Value and Volume, 2016 - 2026)

          1. 5.2.4.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.4.2 South Korea (Value and Volume, 2016 - 2026)

          1. 5.2.4.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.4.3 China (Value and Volume, 2016 - 2026)

          1. 5.2.4.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.4.4 India (Value and Volume, 2016 - 2026)

          1. 5.2.4.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.4.5 Australia (Value and Volume, 2016 - 2026)

          1. 5.2.4.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.4.6 Vietnam (Value and Volume, 2016 - 2026)

          1. 5.2.4.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.4.7 Malaysia (Value and Volume, 2016 - 2026)

          1. 5.2.4.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        8. 5.2.4.8 Indonesia (Value and Volume, 2016 - 2026)

          1. 5.2.4.8.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        9. 5.2.4.9 Philippines (Value and Volume, 2016 - 2026)

          1. 5.2.4.9.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        10. 5.2.4.10 Thailand (Value and Volume, 2016 - 2026)

          1. 5.2.4.10.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        11. 5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2026)

          1. 5.2.4.11.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.2.5.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.5.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.2.5.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.5.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.2.5.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.5.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.2.5.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.5.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016- 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company profiles

      1. 7.1.1 Novo Nordisk

      2. 7.1.2 Sanofi

      3. 7.1.3 Eli Lilly and Company

      4. 7.1.4 Medtronic

      5. 7.1.5 Insulet

      6. 7.1.6 Ypsomed

      7. 7.1.7 Becton, Dickinson and Company

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Insulin Delivery Devices Market market is studied from 2016 - 2027.

The Insulin Delivery Devices Market is growing at a CAGR of 3.5% over the next 5 years.

The Insulin Delivery Devices Market is valued at 33 Billion USD in 2016.

The Insulin Delivery Devices Market is valued at 42 Billion USD in 2027.

North America is growing at the highest CAGR over 2021- 2026.

Asia Pacific holds highest share in 2021.

Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company are the major companies operating in Insulin Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!